PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Analysis indicates a third H1N1 pandemic wave unlikely in 2010

2010-10-19
(Press-News.org) Analysis of H1N1 antibody levels (seroprotection rates) after the 2009 pandemic suggest that a third wave is unlikely in 2010, although adults over age 50, particularly those with chronic conditions, should be immunized for the fall flu season, states a research paper in CMAJ (Canadian Medical Association Journal) (pre-embargo link only) http://www.cmaj.ca/embargo/cmaj100910.pdf.

The study, by researchers from the BC Centre for Disease Control, University of British Columbia and BC Biomedical Laboratories, compared blood levels of antibodies against the H1N1 influenza before and after the 2009 pandemic. They looked at 1127 people in British Columbia's Lower Mainland aged 9 months to 101 years.

Samples collected before the pandemic indicated that less than 10% of children and adults under age 70 had protective levels of H1N1 antibodies whereas 77% of people over age 80 had protective levels. In follow up after the waves of infection and the fall 2009 immunization campaign, the researchers found a 70% protection rate in people under age 20 but lower seroprotection rates in adults aged 20-49 (44%) and 50-79 years of age (30%). People aged 70-79 years had the lowest rate of antibodies (21%) whereas those over 80 years had higher rates.

"The higher percentage with seroprotection we observed in the young may have resulted from higher pandemic H1N1 infection rates and earlier prioritization of pandemic H1N1 vaccine to young children," writes Dr. Danuta Skowronski, BC Centre for Disease Control and University of British Columbia with coauthors.

They estimate that a community-level protection above 40% would be enough to prevent a large epidemic in a population, especially if school-age children who generally contribute most to the spread of influenza are protected. Given that the overall seroprotection rate is estimated at 46% and 70% in school-age children, "these findings reassure against the likelihood of a substantial third pandemic H1N1 wave during the 2010-11 season, unless there is a significant waning of antibody or change in the virus" the authors state.

"Adults 50-79 years exhibited the lowest seroprotection and also remain at higher risk of severe outcomes if infected," they caution. "Our findings support a shift from the prioritized immunization of the young that occurred in fall 2009 to prioritized immunization of older adults for the coming 2010-11 influenza season to protect against severe outcomes due to both pandemic and seasonal influenza."

INFORMATION:

END



ELSE PRESS RELEASES FROM THIS DATE:

Lessons learned from the H1N1 pandemic

2010-10-19
The H1N1 pandemic influenza provided several important lessons that may help in preparing for future influenza outbreaks, write Drs. Donald Low and Allison McGeer in an analysis in CMAJ (Canadian Medical Association Journal) (pre-embargo link only) http://www.cmaj.ca/embargo/cmaj100900.pdf. Although the death rate was lower than initially projected, the years of life lost was significant because "deaths from the 2009 pandemic were skewed toward younger ages than deaths from seasonal influenza," write the authors, both affiliated with Mount Sinai Hospital and the University ...

Tackling cognitive deficits in Alzheimer's disease: 1 'STEP' at a time

2010-10-19
Lowering levels of a key protein involved in regulating learning and memory—STtriatal-Enriched tyrosine Phosphatase (STEP)—reversed cognitive deficits in mice with Alzheimer's disease, Yale School of Medicine researchers report in the October 18 issue of Proceedings of the National Academy of Sciences. "This finding provides a rationale for drug discovery and for developing therapeutic agents that could inhibit STEP proteins and might improve the outlook for Alzheimer's disease patients," said senior author of the study Paul Lombroso, M.D., professor in the Yale Child ...

Beta carotene and retinitis pigmentosa

2010-10-19
CHICAGO—Today's Scientific Program of the 2010 American Academy of Ophthalmology (AAO) - Middle East-Africa Council of Ophthalmology (MEACO) Joint Meeting includes a report on beta carotene's ability to improve vision in people with certain incurable retinal diseases. The AAO-MEACO meeting–the world's largest, most comprehensive ophthalmic education conference–is in session October 16 through 19 at McCormick Place, Chicago. 9-cis Beta-Carotene Mat Boost Vision in Some Patients with Incurable Retinal Disease Retinitis pigmentosa (RP) is a cluster of hereditary disorders ...

New evidence of the power of open access

2010-10-19
New findings settle one of the arguments about Open Access (OA) research publications: Are they more likely to be cited because they were made OA, or were they made OA because they were more likely to be cited? The study, which will be published in PLoS ONE on the first day of Open Access Week (18 October), was carried out by a bi-national team of researchers from the University of Southampton's School of Electronics and Computer Science (ECS) in the UK and l'Université du Québec à Montréal in Canada. The results show that the OA citation impact advantage is just ...

Surgical complications drop at hospitals that share patient safety data

2010-10-19
ANN ARBOR, Mich. – Michigan hospitals reduced surgical complications by nearly 10 percent at a time when the rest of the nation saw no change in complication rates, according to a new study out next week in the Archives of Surgery. Complications dropped at hospitals participating in what's called the Michigan Surgical Quality Collaborative, a group of 16 hospitals led by the University of Michigan Health System that agreed to pool data and share information about what keeps patients safe. The fewer patients suffering ventilator associated pneumonias alone, among the ...

News and insights in gastroenterology presented at the ACG's 75th Annual Meeting

2010-10-19
Bethesda, Maryland (October 14, 2010) – Many of the world's preeminent gastroenterologists will gather for the American College of Gastroenterology's (ACG) 75th Annual Scientific Meeting at the Henry B. Gonzalez Convention Center in San Antonio, Texas starting Monday October 18, 2010, to review the latest scientific advances in gastrointestinal research, treatment of digestive diseases and clinical practice management. Innovative technologies for the diagnosis and treatment of digestive diseases; insights into digestive health conditions, their causes and how they impact ...

Allergy drug found to clear condition but not symptoms of throat disease

2010-10-19
ROCHESTER, Minn. -- A group of Mayo Clinic (http://www.mayoclinic.org/about/) researchers conducted the first controlled trial of swallowed fluticasone nasal spray (also known as Flonase) on people with the allergic esophageal condition called eosinophilic esophagitis (http://www.mayoclinic.org/eosinophilic-esophagitis/). Research showed that the aerosolized swallowed allergy drug helped treat the cause of the throat condition, but symptoms lingered. The researchers' findings were presented today at the Annual Scientific Meeting of the American College of Gastroenterology ...

The protein NOS2 isn't good for ER-negative breast cancer patients

2010-10-19
Breast cancers can be divided into different subtypes based on several criteria, including whether or not they express the protein to which the female hormone estrogen binds; that is, the estrogen receptor (ER). Patients with ER-negative breast tumors have a worse outlook than those with ER-positive breast tumors. However, even among ER-negative breast tumors, those characterized as basal-like are the most aggressive and difficult to treat. New therapeutic targets for this subtype of breast cancer are urgently needed. Now, a team of researchers, led by Stefan Ambs, at the ...

JCI online early table of contents: Oct. 18, 2010

2010-10-19
EDITOR'S PICK: The protein NOS2 isn't good for ER-negative breast cancer patients Breast cancers can be divided into different subtypes based on several criteria, including whether or not they express the protein to which the female hormone estrogen binds; that is, the estrogen receptor (ER). Patients with ER-negative breast tumors have a worse outlook than those with ER-positive breast tumors. However, even among ER-negative breast tumors, those characterized as basal-like are the most aggressive and difficult to treat. New therapeutic targets for this subtype of breast ...

Medicare hospital comparison website may not help patients locate best places for high-risk surgery

2010-10-19
Information available on a government Web site designed to help patients choose high-quality hospitals does not appear to help Medicare beneficiaries identify facilities with better outcomes for high-risk surgeries, according to a report in the October issue of Archives of Surgery, one of the JAMA/Archives journals. In an effort to reduce variations in surgical quality, the Centers for Medicare and Medicaid Services (CMS) now requires hospitals to report data from the national Surgical Care Improvement Project involving measures taken to prevent infection and blood clots, ...

LAST 30 PRESS RELEASES:

The most effective diabetes drugs don't reach enough patients yet

Breast cancer risk in younger women may be influenced by hormone therapy

Strategies for staying smoke-free after rehab

Commentary questions the potential benefit of levothyroxine treatment of mild hypothyroidism during pregnancy

Study projects over 14 million preventable deaths by 2030 if USAID defunding continues

New study reveals 33% gap in transplant access for UK’s poorest children

Dysregulated epigenetic memory in early embryos offers new clues to the inheritance of polycystic ovary syndrome (PCOS)

IVF and IUI pregnancy rates remain stable across Europe, despite an increasing uptake of single embryo transfer

It takes a village: Chimpanzee babies do better when their moms have social connections

From lab to market: how renewable polymers could transform medicine

Striking increase in obesity observed among youth between 2011 and 2023

No evidence that medications trigger microscopic colitis in older adults

NYUAD researchers find link between brain growth and mental health disorders

Aging-related inflammation is not universal across human populations, new study finds

University of Oregon to create national children’s mental health center with $11 million federal grant

Rare achievement: UTA undergrad publishes research

Fact or fiction? The ADHD info dilemma

Genetic ancestry linked to risk of severe dengue

Genomes reveal the Norwegian lemming as one of the youngest mammal species

Early birds get the burn: Monash study finds early bedtimes associated with more physical activity

Groundbreaking analysis provides day-by-day insight into prehistoric plankton’s capacity for change

Southern Ocean saltier, hotter and losing ice fast as decades-long trend unexpectedly reverses

Human fishing reshaped Caribbean reef food webs, 7000-year old exposed fossilized reefs reveal

Killer whales, kind gestures: Orcas offer food to humans in the wild

Hurricane ecology research reveals critical vulnerabilities of coastal ecosystems

Montana State geologist’s Antarctic research focuses on accumulations of rare earth elements

Groundbreaking cancer therapy clinical trial with US Department of Energy’s accelerator-produced actinium-225 set to begin this summer

Tens of thousands of heart attacks and strokes could be avoided each year if cholesterol-lowering drugs were used according to guidelines

Leading cancer and metabolic disease expert Michael Karin joins Sanford Burnham Prebys

Low-intensity brain stimulation may restore neuron health in Alzheimer's disease

[Press-News.org] Analysis indicates a third H1N1 pandemic wave unlikely in 2010